| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Newmeyer JA |
Some considerations on the prevalence of MDMA use |
J Psychoactive Drugs |
1986 |
| Dowling GP, McDonough ET ... |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... |
JAMA |
1987 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Suarez RV, Riemersma R |
'Ecstasy' and sudden cardiac death |
Am J Forensic Med Pa... |
1988 |
| Chadwick IS, Curry PD, Li... |
Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associat... |
J R Soc Med |
1991 |
| Park WK, Azmitia EC |
5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat b... |
Ann N Y Acad Sci |
1991 |
| Rohrig TP, Prouty RW |
Tissue distribution of methylenedioxymethamphetamine |
J Anal Toxicol |
1992 |
| Abbott A, Concar D |
A trip into the unknown |
New Scientist |
1992 |
| Cregg MT, Tracey JA |
Ecstasy abuse in Ireland |
Ir Med J |
1993 |
| Rothwell PM, Grant R |
Cerebral venous sinus thrombosis induced by 'ecstasy' |
J Neurol Neurosurg P... |
1993 |
| Forrest ARW, Galloway JH,... |
A fatal overdose with 3,4-methylenedioxyamphetamine derivatives |
Forensic Sci Int |
1994 |
| Snape MF, Colado MI, et a... |
Chlormethiazole and dizocilpine block the behavioural, but not the neu... |
Pharmacol Toxicol |
1994 |
| Cerruti C, Sheng P, Laden... |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... |
Clin Exp Pharmacol P... |
1995 |
| Green AR, Cross AJ, Goodw... |
Review of the pharmacology and clinical pharmacology of 3,4-methylened... |
Psychopharmacology (... |
1995 |
| Hanyu S, Ikeguchi K, Imai... |
Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ... |
Eur Neurol |
1995 |
| Cox DE, Williams KR |
ADAM' or EVE'?--a toxicological conundrum |
Forensic Sci Int |
1996 |
| Milroy CM, Clark JC, Forr... |
Pathology of deaths associated with 'ecstasy' and 'eve' misuse |
J Clin Pathol |
1996 |
| Sabol KE, Lew R, Richards... |
Methylenedioxymethamphetamine-induced serotonin deficits are followed ... |
J Pharmacol Exp Ther |
1996 |
| Lew R, Sabol KE, Chou C, ... |
Methylenedioxymethamphetamine-induced serotonin deficits are followed ... |
J Pharmacol Exp Ther |
1996 |
| Cox DE, Williams KR |
'ADAM' or 'EVE'?--a toxicological conundrum |
Forensic Sci Int |
1996 |
| Finch E, Sell L, Arnold D |
Drug workers emphasise that water is not an antidote to drug |
BMJ |
1996 |
| White JM, Bochner F, Irvi... |
The agony of 'ecstasy' |
Med J Aust |
1997 |
| Simantov R, Tauber M |
The abused drug MDMA (Ecstasy) induces programmed death of human serot... |
FASEB J |
1997 |
| Schwartz RH, Miller NS |
MDMA (ecstasy) and the rave: a review |
Pediatrics |
1997 |
| De Souza I, Kelly JP, Har... |
An appraisal of the pharmacological and toxicological effects of a sin... |
Pharmacol Toxicol |
1997 |
| Cohen RS, Cocores J |
Neuropsychiatric manifestations following the use of 3,4-methylenediox... |
Prog Neuropsychophar... |
1997 |
| Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
| Byard RW, Gilbert J, Jame... |
Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... |
Am J Forensic Med Pa... |
1998 |
| Weinmann W, Bohnert M |
Lethal monointoxication by overdosage of MDEA |
Forensic Sci Int |
1998 |
| Ramcharan S, Meenhorst PL... |
Survival after massive ecstasy overdose |
J Toxicol Clin Toxic... |
1998 |
| Bhattacharya SK, Bhattach... |
Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an exp... |
Biogenic Amines |
1998 |
| O'Donohoe A, O'Flynn K, S... |
MDMA toxicity: no evidence for a major influence of metabolic genotype... |
Addiction Biology |
1998 |
| Schwab M, Seyringer E, Br... |
Fatal MDMA intoxication |
Lancet |
1999 |
| Jones AL, Simpson KJ |
Review article: mechanisms and management of hepatotoxicity in ecstasy... |
Aliment Pharmacol Th... |
1999 |
| Malpass A, White JM, Irvi... |
Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-... |
Pharmacol Biochem Be... |
1999 |
| Kelly P |
Does recreational ecstasy use cause long-term cognitive problems? |
Western Journal of M... |
2000 |
| Carter N, Rutty GN, Milro... |
Deaths Associated with MBDB Misuse |
Int J Legal Med |
2000 |
| Boot BP, McGregor IS, Hal... |
MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks |
Lancet |
2000 |
| Daws EC, Irvine RJ, Calla... |
Differential behavioural and neurochemical effects of para-methoxyamph... |
Prog Neuropsychophar... |
2000 |
| Rella JG, Nelson LS, Hoff... |
7 years of 3,4-methylenedioxymethamphetamine (MDMA) toxicity |
Int J Med Toxicol |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Dal Cason TA |
A re-examination of the mono-methoxy positional ring isomers of amphet... |
Forensic Sci Int |
2001 |
| Gesi M, Lenzi P, Soldani ... |
Morphological effects in the mouse myocardium after methylenedioxymeth... |
Anat Rec |
2002 |
| Gill JR, Hayes JA, deSouz... |
Ecstasy (MDMA) deaths in New York City: a case series and review of th... |
J Forensic Sci |
2002 |
| Smith KM, Larive LL, Roma... |
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... |
Am J Health Syst Pha... |
2002 |
| De Letter EA, Belpaire FM... |
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA,... |
Int J Legal Med |
2002 |
| De Letter EA, Clauwaert K... |
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA,... |
Int J Legal Med |
2002 |
| Gesi M, Soldani P, Lenzi ... |
Ecstasy during Loud Noise Exposure Induces Dramatic Ultrastructural Ch... |
Pharmacol Toxicol |
2002 |
| Raikos N, Tsoukali H, Psa... |
Amphetamine derivative related deaths in northern Greece |
Forensic Sci Int |
2002 |
| Goldberger BA, Frost-Pine... |
Ecstasy Deaths in the State of Florida: A Post-Mortem Analysis |
Biol Psych |
2002 |
| Gilhooly TC, Daly AK |
CYP2D6 deficiency, a factor in ecstasy related deaths? |
Br J Clin Pharmacol |
2002 |
| De Letter EA, Clauwaert K... |
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine MDMA, ... |
Int J Legal Med |
2002 |
| De Letter EA, Belpaire FM... |
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine MDMA, ... |
Int J Legal Med |
2002 |
| Carvalho M, Hawksworth G,... |
Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vi... |
Arch Toxicol |
2002 |
| Montiel-Duarte C, Varela-... |
3,4-Methylenedioxymethamphetamine ("Ecstasy") induces apoptosis of cul... |
Biochim Biophys Acta |
2002 |
| Nunez O, Banares R, Barri... |
[Variability of the clinical expression of Ecstasy-induced hepatotoxic... |
Gastroenterol Hepato... |
2002 |
| Kupiec T, DeCicco L, Spie... |
Choice of an ELISA assay for screening postmortem blood for amphetamin... |
J Anal Toxicol |
2002 |
| Traub SJ, Hoffman RS, Nel... |
The "Ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamph... |
J Urban Health |
2002 |
| Vuori E, Henry JA, Ojanpe... |
Death following ingestion of MDMA (ecstasy) and moclobemide |
Addiction |
2003 |
| Peng W, Simantov R |
Altered gene expression in frontal cortex and midbrain of 3,4-methylen... |
J Neurosci Res |
2003 |
| Johansen SS, Hansen AC, M... |
Three fatal cases of PMA and PMMA poisoning in Denmark |
J Anal Toxicol |
2003 |
| Schifano F, Oyefeso A, Co... |
Death rates from ecstasy (MDMA, MDA) and polydrug use in England and W... |
Hum Psychopharmacol |
2003 |
| Bexis S, Phillis BD, Ong ... |
Baclofen prevents MDMA-induced rise in core body temperature in rats |
Drug Alcohol Depend |
2004 |
| Schifano F |
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities |
Psychopharmacology (... |
2004 |
| Carvalho M, Remião F, Mil... |
The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat ... |
Toxicology |
2004 |
| Elliott SP |
MDMA and MDA concentrations in antemortem and postmortem specimens in ... |
J Anal Toxicol |
2005 |
| Schifano F, Deluca P, Ago... |
New trends in the cyber and street market of recreational drugs? The c... |
J Psychopharmacol |
2005 |
| Schifano F, Deluca P, Ago... |
New trends in the cyber and street market of recreational drugs? The c... |
J Psychopharmacol |
2005 |
| Capela JP, Macedo C, Bran... |
Neurotoxicity mechanisms of thioether ecstasy metabolites |
Neuroscience |
2007 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Nakagawa Y, Suzuki T, Tay... |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and ... |
Arch Toxicol |
2009 |
| Schifano F, Corkery J, Na... |
Overview of Amphetamine-Type Stimulant Mortality Data - UK, 1997-2007 |
Neuropsychobiology |
2010 |
| Corazza O, Schifano F |
Near-death states reported in a sample of 50 misusers |
Subst Use Misuse |
2010 |
| Karila L, Reynaud M |
GHB and synthetic cathinones: clinical effects and potential consequen... |
Drug Test Anal |
2010 |
| Lusthof KJ, Oosting R, Ma... |
A case of extreme agitation and death after the use of mephedrone in T... |
Forensic Sci Int |
2011 |
| Kała M, Lechowicz W,... |
[Resurgence in paramethoxamphetamine use: Review of poisonings and two... |
Przegl Lek |
2011 |
| Bassindale T |
Benzylpiperazine: the New Zealand legal perspective |
Drug Test Anal |
2011 |
| Wasik AM, Gandy MN, McIld... |
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethampheta... |
Invest New Drugs |
2011 |
| Kyle PB, Iverson RB, Gaja... |
Illicit bath salts: not for bathing |
J Miss State Med Ass... |
2011 |
| Prosser JM, Nelson LS |
The Toxicology of Bath Salts: A Review of Synthetic Cathinones |
J Med Toxicol |
2012 |
| Wasik AM, Gandy MN, McIld... |
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethampheta... |
Invest New Drugs |
2012 |
| Pálenícek T, Lhotková E, ... |
Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmaco... |
Prog Neuropsychophar... |
2016 |
| Batisse A, Peyrière H, Ei... |
[Use of psychostimulants in a sexual context: Analysis of cases report... |
Therapie |
2016 |
| Hockenhull J, Murphy KG, ... |
Mephedrone use is increasing in London |
Lancet |
2016 |
| Pinterova N, Horsley RR, ... |
Synthetic Aminoindanes: A Summary of Existing Knowledge |
Front Psychiatry |
2017 |
| Saleemi S, Pennybaker SJ,... |
Who is 'Molly'? MDMA adulterants by product name and the impact of har... |
J Psychopharmacol |
2017 |
